BBOT
Financials
- Market Capitalization 706.54 M
- Employee 106
- Founded 2016
- CEO N/A
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG01L3GYF02
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2677 |  AURA Aura Biosciences, Inc. - Common Stock | 7.00 USD | 0.00% | -0.43% | +9.03% | +6.71% | 723.71 M USD | ||
| 2679 |  CADL Candel Therapeutics, Inc. - Common Stock | 9.87 USD | +2.39% | +2.49% | +16.39% | +55.92% | 723.18 M USD | ||
| 2723 |  MNPR Monopar Therapeutics Inc. - Common Stock | 99.79 USD | -3.43% | +6.31% | +64.64% | +82.70% | 668.50 M USD | ||
| 2737 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 34.81 USD | +1.37% | -4.13% | +17.96% | +102.97% | 656.84 M USD |
Frequently asked questions about BridgeBio Oncology Therapeutics, Inc. - Common Stock
What is the BridgeBio Oncology Therapeutics, Inc. - Common Stock stock price today?
The current price of BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT) is 8.82. Over the past 24 hours, the stock has changed by +3.52%. Follow the BBOT chart for real-time price dynamics.
What is the stock ticker of BridgeBio Oncology Therapeutics, Inc. - Common Stock?
BridgeBio Oncology Therapeutics, Inc. - Common Stock trades under the ticker BBOT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BridgeBio Oncology Therapeutics, Inc. - Common Stock stock going up?
BBOT has changed by +1.73% over the last week, +13.51% over the last month, and -7.06% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BridgeBio Oncology Therapeutics, Inc. - Common Stock net income for the last quarter?
BridgeBio Oncology Therapeutics, Inc. - Common Stock reported net income of -42.11 M for the last quarter. The previous quarter showed -38.8 M, which means net income changed by -8.53%.
How many employees does BridgeBio Oncology Therapeutics, Inc. - Common Stock have?
As of the latest available data, BridgeBio Oncology Therapeutics, Inc. - Common Stock has 106 employees. Workforce size can provide additional context about the company's scale and operations.
What is BridgeBio Oncology Therapeutics, Inc. - Common Stock EBITDA?
BridgeBio Oncology Therapeutics, Inc. - Common Stock EBITDA is -42.12 M, and its EBITDA margin is -1 068.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BridgeBio Oncology Therapeutics, Inc. - Common Stock stock?
You can buy BridgeBio Oncology Therapeutics, Inc. - Common Stock (BBOT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BridgeBio Oncology Therapeutics, Inc. - Common Stock stock?
Investing in BridgeBio Oncology Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BBOT chart and related analysis on metatrader.com as part of your research.